Fennec Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Business Update
~ Third Quarter 2026 Net Product Sales of $19.4 Million, Up 56% Year over Year ~
Covered in this story
Call it yourself
No calls on $FENC yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Fennec Pharmaceuticals Inc →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.